Testing Nitrosamine Content in Pharmaceutical Products

Register free: http://www.chromatographyonline.com/lcgc_w/testing_products

Event Overview:

Following on from several recalls of pharmaceutical products, the issue of nitrosamines in drugs has become a high priority. The European Medicines Agency is now requiring risk assessments of nitrosamine exposure risk to be completed by the 26^th of March. This webcast will look at nitrosamines, where they may be formed in a pharmaceutical environment, and how the dedicated nitrosamine detectors can be used in both screening and more detailed analysis.

Key Learning Objectives:

• Learn potential areas nitrosamines could be formed

• Learn how screening for apparent total nitrosamine content can be used to quickly check product conformity

• Learn how dedicated nitrosamine detectors work and what make their use is ideal for nitrosamine analysis

Speaker: Dr. Mark Landon, Technical Director, Ellutia Ltd

Time and date: Tuesday, Mar. 24, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET

On demand available after airing until Mar. 24, 2021

Sponsor: Ellutia

Register free: http://www.chromatographyonline.com/lcgc_w/testing_products